NEW YORK (GenomeWeb) – Affymetrix and Cytox today announced a collaboration to develop and commercialize a blood-based genetic assay for research in diagnosing Alzheimer's disease and mild cognitive impairment (MCI).

Financial and other details of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.